Unity Biotechnology Faces Delisting Concerns
| Field | Detail |
|---|---|
| Company | Unity Biotechnology, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 30, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, corporate-governance
Related Tickers: UBX
TL;DR
UBX might get delisted, big trouble brewing.
AI Summary
Unity Biotechnology, Inc. filed an 8-K on June 30, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule, a departure of directors or officers, and other events. The company, formerly known as Forge Inc. and Cenexys, Inc., is incorporated in Delaware and operates in the pharmaceutical preparations industry.
Why It Matters
This filing indicates potential issues with Unity Biotechnology's continued listing on an exchange, which could significantly impact its stock value and operational stability.
Risk Assessment
Risk Level: high — The filing explicitly mentions a notice of delisting or failure to satisfy a continued listing rule, which is a significant risk for investors.
Key Numbers
- 001-38470 — Commission File Number (Identifies the company's SEC filing number.)
- 26-4726035 — IRS Employer Identification Number (Company's tax identification number.)
Key Players & Entities
- Unity Biotechnology, Inc. (company) — Registrant
- Forge Inc (company) — Former Company Name
- Cenexys, Inc. (company) — Former Company Name
- 285 East Grand Avenue (location) — Business Address
- South San Francisco, CA (location) — Business Address City/State
FAQ
What specific rule or standard has Unity Biotechnology failed to satisfy that led to the notice of delisting?
The filing does not specify the exact rule or standard that Unity Biotechnology has failed to satisfy, only that a notice has been issued.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 27, 2025.
What is Unity Biotechnology's Standard Industrial Classification (SIC) code?
Unity Biotechnology's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Has Unity Biotechnology undergone any name changes in the past?
Yes, Unity Biotechnology was formerly known as Forge Inc. (name change on 20130703) and Cenexys, Inc. (name change on 20090504).
What is the primary purpose of this 8-K filing?
This 8-K filing serves to report a notice of delisting or failure to satisfy a continued listing rule, departure of directors or officers, and other events.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 30, 2025 regarding Unity Biotechnology, Inc..